Literature DB >> 2804029

Local extraocular extension of retinoblastoma following intraocular surgery.

K E Stevenson1, J Hungerford, A Garner.   

Abstract

Three cases of local extraocular extension of retinoblastoma following intraocular surgery via a transscleral approach have been seen in one centre during a 12-month period. This number represents a significant increase on the previous incidence of this serious complication, which may be related to more widespread use of vitrectomy techniques. Orbital and local lymph node recurrence of retinoblastoma have been associated with a very poor survival rate in the past, and steps must be taken to limit the chance of this happening should an intraocular surgical procedure be performed inadvertently on an eye containing a retinoblastoma. Early enucleation without implant is advised, and adjuvant orbital radiotherapy is strongly recommended, even when there is no histopathological evidence of local extraocular tumour spread.

Entities:  

Mesh:

Year:  1989        PMID: 2804029      PMCID: PMC1041868          DOI: 10.1136/bjo.73.9.739

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Diagnosis of retinoblastoma by cytologic examination of the aqueous and the vitreous.

Authors:  A Rodriguez
Journal:  Mod Probl Ophthalmol       Date:  1977

2.  Retinoblastoma in Finland 1912-1964.

Authors:  A Tarkkanen; E Tuovinen
Journal:  Acta Ophthalmol (Copenh)       Date:  1971

3.  Retinoblastomas initially misdiagnosed as primary ocular inflammations.

Authors:  W R Stafford; M Yanoff; B L Parnell
Journal:  Arch Ophthalmol       Date:  1969-12

4.  Orbital recurrence of retinoblastoma.

Authors:  J Hungerford; J Kingston; N Plowman
Journal:  Ophthalmic Paediatr Genet       Date:  1987-03
  4 in total
  9 in total

1.  Intravitreal chemotherapy for recurrent retinoblastoma in an only eye.

Authors:  S Seregard; E Kock; E af Trampe
Journal:  Br J Ophthalmol       Date:  1995-02       Impact factor: 4.638

2.  A delayed diagnosis of unsuspected retinoblastoma in an in vitro fertilisation infant with retinopathy of prematurity.

Authors:  Tian Tian; Xun-Da Ji; Qi Zhang; Jie Peng; Pei-Quan Zhao
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

Review 3.  Applications of monoclonal antibodies in the investigation, diagnosis, and treatment of retinoblastoma.

Authors:  J F Tarlton; D L Easty
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

4.  Orbital Recurrence following Aggressive Laser Treatment for Recurrent Retinoblastoma.

Authors:  Bradley H Jacobsen; Jesse L Berry; Rima Jubran; Jonathan W Kim
Journal:  Ocul Oncol Pathol       Date:  2015-09-18

5.  Segmental Scleral Buckle Surgical Technique for Repair of a Rhegmatogenous Retinal Detachment in Retinoblastoma: A Case and Review of the Literature.

Authors:  Sydney P Wendt; Dianne A Barrett; Emmanuel Y Chang; Amy C Schefler
Journal:  Ocul Oncol Pathol       Date:  2020-12-22

6.  Orbital relapse of retinoblastoma in patients with high-risk histopathology features.

Authors:  Maria Vittoria Cicinelli; Swathi Kaliki
Journal:  Ther Adv Ophthalmol       Date:  2019-04-26

7.  Long-Term Clinical Results and Management following Vitrectomy in Undetected Retinoblastoma Eyes.

Authors:  Eva Biewald; Sabrina Schlüter; Nikolaos E Bechrakis; Tobias Kiefer; Philipp Rating; Dirk Geismar; Klaus A Metz; Sophia Göricke; Petra Ketteler; Norbert Bornfeld
Journal:  Ocul Oncol Pathol       Date:  2020-02-25

8.  Head and Eye Trauma Before Retinoblastoma Diagnosis.

Authors:  Rongxin Chen; Huijing Ye; Shu Liu; Yueyan Lin; Wei Xiao; Shaowei Bi; Guo Chen; Te Zhang; Jingqiao Chen; Huasheng Yang
Journal:  Cancer Manag Res       Date:  2019-12-06       Impact factor: 3.989

9.  Pars Plana Vitrectomy and Evisceration Resulting in Death Due to Misdiagnosis of Retinoblastoma in Children: A Review of 3 Cases.

Authors:  Tao Shen; Rongjiao Liu; Jing Lin; Huiqun Huang; Xiuling Li; Jianhua Yan
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.